← TrialMatch
HomeTrials

Rotofunc - Non-traumatic Shoulder Instability and Total Rotator Cuff Function

The goal of this clinical trial is to test the effect of a novel assessment and treatment strategy for young adults with severely disabling non-traumatic shoulder instability. The main question it aims to answer is if this treatment will substantially change the patients shoulder function to a more stable and controlla

Condition(s)Shoulder Dislocation or Subluxation
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe goal of this clinical trial is to test the effect of a novel assessment and treatment strategy for young adults with severely disabling non-traumatic shoulder instability. The main question it aims to answer is if this treatment will substantially change the patients shoulder function to a more stable and controllable state and thereby give a higher quality of life. Participants failure in active shoulder muscle function will be assessed and exercises will be selected individually. Patients will be asked to perform the exercises twice per day. At clinical visits to a specialized physiotherapist the exercises will be upgraded to restore full dynamic stability throughout shoulder movement range. The active treatment period will be 4 months. Researchers will compare two groups. One group
Who can participateInclusion Criteria: * young adults, non traumatic as well as non-controllable, positional, functional shoulder instability according to Moroder et al. demonstrating a lack of ≥ 20%, active, dynamic control compared with the total passive range of motion in shoulder rotation with or without previous shoulder stabilizing surgery * Understanding the Swedish language well, in speaking, in reading and writing. Exclusion Criteria: * Other significant shoulder pathologies, patients diagnosed with severe systemic connective tissue, congenital anatomic abnormalities, or psychiatric diagnoses according to previous medical records * \<60% adherence to assigned exercises
Ages16 Years to 35 Years
SexAll
Lead sponsorSahlgrenska University Hospital
LocationsGothenburg, Mölndal, Sweden
Start date2023-05-01
NCT IDNCT06261645
Official listinghttps://clinicaltrials.gov/study/NCT06261645

🔍 Search all trials →